Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era

The prognostic value of pretreatment serum beta-2 microglobulin (B2MG) level in advanced Hodgkin lymphoma (HL) patients treated in the modern era has not been well established. We conducted a retrospective study involving 202 advanced classical HL (cHL) patients treated from 1998.5 to 2015.7 to eval...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Wang, Qin, Qin, Yan, Zhou, Shengyu, He, Xiaohui, Yang, Jianliang, Kang, Suyi, Liu, Peng, Yang, Sheng, Zhang, Changgong, Gui, Lin, Sun, Yan, Shi, Yuankai
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342156/
https://ncbi.nlm.nih.gov/pubmed/27750215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12663
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars